# JY231 Injection for the Treatment of Relapsed/Refractory Neurologic Immune Disorders

> **NCT06797024** · NA · RECRUITING · sponsor: **Tongji Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Autoimmune Diseases of the Nervous System

## Interventions

- **DRUG:** JY231 Injection

## Key facts

- **NCT ID:** NCT06797024
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-28
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06797024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06797024, "JY231 Injection for the Treatment of Relapsed/Refractory Neurologic Immune Disorders". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06797024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*